|
ADPGK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.921000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.856200E-01 |
| Normal-vs-Stage2 |
1.113610E-01 |
| Normal-vs-Stage3 |
6.547400E-01 |
| Normal-vs-Stage4 |
5.861200E-01 |
| Stage1-vs-Stage2 |
4.160400E-02 |
| Stage1-vs-Stage3 |
2.809600E-01 |
| Stage1-vs-Stage4 |
8.248600E-01 |
| Stage2-vs-Stage3 |
1.812360E-01 |
| Stage2-vs-Stage4 |
6.941500E-02 |
| Stage3-vs-Stage4 |
3.741800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.243800E-01 |
| Normal-vs-AfricanAmerican |
4.943600E-01 |
| Normal-vs-Asian |
6.290000E-01 |
| Caucasian-vs-AfricanAmerican |
5.840800E-01 |
| Caucasian-vs-Asian |
6.557800E-01 |
| AfricanAmerican-vs-Asian |
8.442400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.764200E-01 |
| Normal-vs-Female |
6.371800E-01 |
| Male-vs-Female |
6.376200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.151200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.105800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.684400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.097400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.902210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.840200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.846400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.848000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.781600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.148200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.313800E-02 |
| Classical-VS-Follicular |
2.177800E-03 |
| Classical-VS-Other |
9.507400E-01 |
| Classical-VS-Normal |
2.019800E-01 |
| Tall-VS-Follicular |
5.111400E-01 |
| Tall-VS-Other |
3.555200E-01 |
| Tall-VS-Normal |
3.688200E-01 |
| Follicular-VS-Other |
3.084200E-01 |
| Follicular-VS-Normal |
7.277700E-02 |
| Other-VS-Normal |
5.529000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.960600E-01 |
| Normal-vs-N1 |
8.865400E-01 |
| N0-vs-N1 |
5.175000E-01 |
|
|
